142.00
-1.90
(-1.32%)
At close: April 17 at 5:31:31 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
934,278
934,278
1,074,386
1,144,261
946,623
Cost of Revenue
613,680
613,680
683,920
706,190
538,054
Gross Profit
320,598
320,598
390,466
438,071
408,569
Operating Expense
245,025
245,025
254,499
290,236
265,641
Operating Income
75,573
75,573
135,967
147,835
142,928
Net Non Operating Interest Income Expense
2,039
2,039
3,177
-1,093
-3,813
Pretax Income
78,277
78,277
133,805
142,485
137,925
Tax Provision
10,613
10,613
1,730
21,359
16,266
Net Income Common Stockholders
67,664
67,664
132,075
121,126
121,659
Diluted NI Available to Com Stockholders
67,664
67,664
132,075
121,126
121,659
Basic EPS
5.30
--
10.34
9.53
9.95
Diluted EPS
5.29
--
10.30
9.47
9.88
Basic Average Shares
12,766.55
--
12,770.05
12,716.27
12,225.18
Diluted Average Shares
12,781.20
--
12,820.77
12,788.31
12,318.82
Total Operating Income as Reported
75,573
75,573
135,967
147,835
145,517
Total Expenses
858,705
858,705
938,419
996,426
803,695
Net Income from Continuing & Discontinued Operation
67,664
67,664
132,075
121,126
121,659
Normalized Income
76,102.44
76,102.44
126,768.51
123,179.69
125,825.88
Interest Income
5,357
5,357
4,494
383
31
Interest Expense
3,177
3,177
1,332
1,476
4,182
Net Interest Income
2,039
2,039
3,177
-1,093
-3,813
EBIT
81,454
81,454
135,137
143,961
142,107
EBITDA
148,259
148,259
205,931
211,015
201,151
Reconciled Cost of Revenue
613,680
613,680
683,920
706,190
538,054
Reconciled Depreciation
66,805
66,805
70,794
67,054
59,044
Net Income from Continuing Operation Net Minority Interest
67,664
67,664
132,075
121,126
121,659
Total Unusual Items Excluding Goodwill
-9,762
-9,762
5,376
-2,548
-4,724
Total Unusual Items
-9,762
-9,762
5,376
-2,548
-4,724
Normalized EBITDA
158,021
158,021
200,555
213,563
205,875
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,323.56
-1,323.56
69.51
-494.31
-557.12
12/31/2021 - 4/3/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
YPSN.SW Ypsomed Holding AG
317.00
-2.91%
GXI.F Gerresheimer AG
51.85
+1.87%
STMN.SW Straumann Holding AG
96.92
+1.49%
0SKN.IL SKAN Group AG
62.50
+0.81%
SR3.F STAAR Surgical Company
14.19
-1.11%
ALCz.XC
VBSN.SW IVF Hartmann Holding AG
159.00
+0.63%
CLTN.SW COLTENE Holding AG
59.70
+1.19%
AFX.F Carl Zeiss Meditec AG
56.30
-0.71%
SKAN.SW SKAN Group AG
62.80
+0.80%